To understand the regulation, evolution, and genetics of lp A2 /Edg4, a second lysophosphatidic acid receptor gene, we characterized its complete cDNA sequence, genomic structure, and chromosomal location. The full-length mouse transcript sequence was determined using rapid amplification of cDNA ends. Southern blot and restriction fragment length polymorphism segregation analyses revealed that the mouse gene was present as a single copy and located at the middle of Chromosome 8 near the mutations for myodystrophy (myd) and "kidney-anemia-testes" (kat). This region is syntenic with human chromosome 19p12, where the human genomic clone containing the lp A2 gene (EDG4) was mapped. Sequence analysis of genomic clones demonstrated that both mouse and human transcripts were encoded by three exons, with an intron separating the coding region for transmembrane domain VI. Reverse transcriptase-PCR demonstrated that the three exons were spliced in all mouse tissues shown to express the transcript. Finally, in a comparison of all human lp A2 sequences present in the database, we identified several sequence variants in multiple tumors. One such variant (a G deletion) in the initially characterized Edg4 cDNA clone (derived from an ovarian tumor) results in a frameshift mutation near the 3 end of the coding region. In addition to increasing our understanding of the mechanisms underlying lysophosphatidic acid signaling and lysophospholipid receptor gene evolution, these results have important implications regarding the genomic targeting and oncogenic potential of lp A2 .
INTRODUCTION
Lysophospholipids such as lysophosphatidic acid (LPA) and sphingosine-1-phosphate (S1P) are extracellular signaling molecules produced by various cell types, including activated platelets (reviewed in Durieux, 1995; Moolenaar et al., 1997) . LPA and S1P activate specific G-protein-coupled receptors (GPCRs), thereby causing a wide array of cellular effects, such as increased proliferation, Rho-dependent morphological changes, and increased ion conductances in membranes (e.g., van Corven et al., 1989; Ridley and Hall, 1992; Fernhout et al., 1992) . The first identified lysophospholipid receptor gene, lp A1 (also called vzg-1/ Edg2/mrec1.3/Gpcr26), specifically interacts with LPA (Hecht et al., 1996; Fukushima et al., 1998; Chun et al., 1999) . Upon initial searches of GenBank, two groups of similar receptor sequences were identified: those encoded by the Edg1, H218/Agr16, and Edg3 orphan receptor genes, with 32-36% amino acid sequence identity to lp A1 , and those encoded by the Cnr1 (CB1) and Cnr2 (CB2) cannabinoid receptor genes, with approximately 28% amino acid identity to lp A1 (Contos and Chun, 1998) The endogenous cannabinoid receptor ligands (anandamide and 2-arachidonylglycerol) are lipid molecules with structures similar to those of lysophospholipids (Felder et al., 1993; Stella et al., 1997) . We and others determined that the Edg1, H218/Agr16, and Edg3 genes encode high-affinity receptors for S1P Lee et al., 1998; Zondag et al., 1998; Zhang et al., 1999) . We thus refer to our characterized mouse clones for these genes as lp B1 , lp B2 , and lp B3 , respectively (Zhang et al., 1999; Contos and Chun, 1998) .
In the course of genomic characterization of the mouse lp A1 gene, another GenBank search revealed a novel human genomic sequence that encoded a receptor with 55% identity to lp A1 (Contos and Chun, 1998) . Such high identity, of magnitude similar to that within the lp B subfamily or within other GPCR subfamilies that bind the same ligand, suggested that this receptor was a high-affinity LPA receptor and should be clustered in the same subfamily as lp A1 . We thus termed this gene lp A2 (Contos and Chun, 1998) . Concurrently with our studies, it was shown that overexpression of the human lp A2 gene (called EDG4) 2 could potentiate LPA responsivity, but not S1P responsivity, on a cell line, supporting the hypothesis that this was a second LPA receptor gene .
A characterization was undertaken to understand several aspects of the lp A2 gene more clearly: (1) its complete genomic structure, (2) cis-elements controlling its expression, (3) its chromosomal location, and (4) its evolutionary relationship to other lp receptor genes. Furthermore, mouse lp A2 genomic characterization is requisite for the generation of mice with a targeted deletion of the gene, which would allow analysis of lp A2 biological function in the whole animal. Previous characterization of the mouse lp A1 gene provided a basis for the analysis of lp A2 (Contos and Chun, 1998) . The coding region of lp A1 is spread over two or three exons, depending on which of the multiple 5Ј exons is found in the transcript. One intron is located within the coding region for transmembrane domain VI, an insertion site not found in other GPCR gene subfamilies, including the lp B and Cnr genes, which are intronless in their coding region (Liu and Hla, 1997; Abood et al., 1997; Zhang et al., 1999) . While the entire lp A1 gene is located on mouse Chromosome 4, the last exon is duplicated on Chromosome 6 in some mouse strains. With this background in mind, we isolated and characterized mouse lp A2 genomic clones. We found that although lp A2 has a conserved intron similar to that in lp A1 , there is only one primary exon. The two coding exons are present as single copies in Mus musculus and are located at the central part of mouse Chromosome 8. In addition, we determined that the previously characterized Edg4 cDNA clone has a guanine nucleotide deletion that causes a frameshift near its C-terminal coding region. This likely reflects a somatic mutation in the ovary tumor cells from which the cDNA was isolated and may have altered the function of the encoded receptor.
MATERIALS AND METHODS

5Ј and 3Ј rapid amplification of cDNA ends (RACE).
For both 5Ј and 3Ј RACE, we utilized Marathon cDNA templates from different mouse tissues (Clontech). After a primary PCR, products were diluted 1:20, and 1 L was used as template in a secondary PCR with nested primers on either end. PCRs of 50 L consisted of 1ϫ PCR buffer B [75 mM Tris, pH 9.0, 15 mM (NH 4 ) 2 SO 4 ], 3 0.25 mM each dNTP, 0.5 mM each primer, 1 L of template, and 0.5 U Pfu (added after the reaction mix was overlaid with mineral oil and heated to 90°C). Reaction mixes were cycled 35ϫ (95°C for 30 s, 60°C for 30 s, and 72°C for 3 min). Of the many lp A2 gene primer combinations tried, the following combinations gave clear products that could be subcloned: 5Ј RACE, edg6tЈ/AP1 and then edg6e/AP2; 3Ј RACE, edg6a/AP1 and then edg6o/AP2 4 (oligonucleotide sequences are listed in Table 1 ). The 5Ј RACE products were subcloned into pBluescript SK( ϩ ) (Stratagene) using two enzymes whose restriction sites were at the ends of the final PCR product: SacI (in edg6e) and XmaI (by AP2). Colonies were grown with blue/white selection and white colonies screened using PCR (edg6e/T7). 3Ј RACE products were subcloned using blunt/sticky (product digested with NotI and 4-cutters listed below; pBS digested with EcoRV/NotI) or blunt/blunt ligations (product digested separately with AluI, HaeIII, BstUI, or RsaI; pBS digested with EcoRV). This "shotgun" technique allowed rapid sequencing of the 1.8-kb 3Ј RACE product.
Genomic Southern blot analysis. Genomic DNA (20 g) from a M. musculus mixed background strain (C57BL/6J ϫ Balb/C) was 10-fold overdigested with the restriction enzymes indicated in Fig. 2 . Conditions for making and probing the Southern blots are detailed elsewhere (Contos and Chun, 1998) , with the exceptions listed below. Probe fragments were purified with the Qiaquick gel extraction kit (Qiagen) after PCR amplification from genomic clone templates. Labeled probes (edg6a/edg6b and edg6e3b/edg6mЈ) were hybridized at a concentration of 1.5 ϫ 10 6 dpm/mL instead of 1.0 ϫ 10 6 dpm/mL. After being air-dried, the blot was exposed at Ϫ80°C to Kodak MS film in a cassette containing two regular intensifying screens and the special HE (high-energy) screen (Kodak). The more sensitive film and intensifying screen allowed exposure times to be reduced approximately 5-fold (Southen blots shown in Fig. 2 were exposed for 40 h). 2 The approved symbol for the lp A2 /Edg4 gene is Edg4 for mouse and EDG4 for human.
3 All chemical reagents used were purchased from Sigma, with the exceptions of radionucleotides (Dupont), random hexamers/T3 polymerase/T7 polymerase/RNasin (Boehringer Mannheim), sequencing reagents (USB), and others where noted. All restriction and modifying enzymes used were purchased from from New England Biolabs, with the exception of Taq and Superscript (Gibco), Pfu polymerase (Stratagene), and Sequenase (Amersham). edg6a  5Ј-CGAGACCATCGGTTTCTTCTATA-3Ј  edg6aЈ  5Ј-CGAGACCATCGGCTTTTTCTATA-3Ј  edg6b  5Ј-CCCAGGATGATGACAACAGTCTT-3Ј  edg6bЈ  5Ј-CCCAGAATGATGACAACCGTCTT-3Ј  edg6c  5Ј-CTCATGTTCCACACTGGTCC-3Ј  edg6d  5Ј-AAGCCCTGCCGCAGGAACCA-3Ј  edg6e  5Ј-CTGAGCTCCAAGCCGCTGTT-3Ј  edg6f  5Ј-GACCACACTCAGCCTAGTCA-3Ј  edg6h  5Ј-TCCTCAGCCCTGGTTGGTTT-3Ј  edg6i4  5Ј-GGCCAGCCTGGTCTACCAA-3Ј  edg6i5  5Ј-GCAGAGGCAGGCAGAACTTTT-3Ј  edg6Te15Ј  5Ј-GCCATGGGTCTCAGTCCTGCTTCAA-3Ј  edg6mЈ 5Ј
Genomic clone isolation and restriction mapping. A PCR strategy (detailed in Contos and Chun, 1998 ) was used to isolate clones from a 129/SvJ genomic library in Lambda FIX II (Stratagene). PCR with the initially designed primers (edg6a/6b) gave a specific product of the expected size (ϳ714 bp) using mouse 129/SvJ genomic DNA as template. This product was confirmed to be lp A2 by T/A subcloning (see below) and sequencing. Using the edg6a/6b PCR, we screened a total of approximately 460,000 clones (46 wells ϫ 10,000 clones/well) and isolated three positives after tertiary screens by conventional plaque hybridization. 5 The three pure phage clones were grown by liquid lysate, and DNA was isolated with the Wizard Prep Kit (Promega). All three clones were characterized by restriction mapping, making use of sites that flank each side of the insert (XbaI, SacI, SalI, and NotI). Since no NotI or SalI sites were found in any of the inserts, we double-digested with one of these enzymes (NotI) to map EcoRI, HindIII, XhoI, or BamHI sites (in addition to single digestions with each). Digested clones were electrophoresed, Southern blotted (as above), and then probed with the edg6a/6b probe. PCRs using the primers edg6a, edg6b, edg6c, edg6d, edg6e, or edg6h with T7 or T3 (both T3 and T7 flank the inserts) allowed determination of orientations and more precise relative locations of the exon amplified by edg6a/6b. Restriction maps were constructed utilizing all these data, as well as the determined sequence.
Subcloning and sequencing. Inserts from the purified clone DNA were subcloned for ease of larger preparations, finer restriction mapping, and the obtainment of templates that could be sequenced manually. Table 2 lists the fragments subcloned and names of the plasmids containing them. In addition to genomic clones, other subcloned fragments (from PCR and RACE) are listed. Subcloning of genomic fragments and 5Ј RACE products was usually performed using an in-gel ligation protocol, described elsewhere (Contos and Chun, 1998) . Digested 3Ј RACE products were subcloned with the same protocol, except inserts were simply heat-treated, ethanol precipitated, and resuspended (in place of the insert being gel-purified). The edg6a/edg6b PCR product (amplified with regular Taq, which tends to add an A at the 3Ј ends) was T/A subcloned by adding a T onto the ends of EcoRV-digested pBS (Marchuk et al., 1991) . Cloning vector (pBS) was almost always treated with calf intestinal alkaline phosphatase briefly after restriction digestion. Subcloned inserts were sequenced using the dideoxy method and T3, T7, or reverse primers that flank the multiple cloning site or with oligonucleotides designed to insert sequence (Sanger et al., 1977) .
DNA sequence analysis. Raw sequence data were read into files and assembled into contigs using the DNasis software program (Hitachi). The human genomic cosmid and Edg4 cDNA sequences were downloaded from GenBank at the NCBI Web site (http://www.ncbi. nlm.nih.gov). Searches (with parts of these sequences) were then performed using the BLAST algorithm (Altschul et al., 1990) in both the nonredundant (nr) and the EST (dbEST) databases, also at the NCBI Web site. Alignments of all ESTs were made with DNasis.
However, where substantial parts of the sequences became very divergent from the consensus, they were separated and aligned independently. Repetitive elements (Smit, 1996) were determined using RepeatMasker (A. F. A. Smit and P. Green; http://ftp.genome. washington.edu/RM/RepeatMasker.html). All sequences determined here were deposited with GenBank. Human sequence variations not noted in Fig. 8 included EST AA298791 (CTG CTT GTT), which differed from the genomic and Edg4 cDNA clone sequences (CTG CTT GTC), but did not change the encoded amino acid. In additon, EST AA312795 (AAT GTT GCT) differed from three other sequences (AAT GCT GCT), though the amino acid change was conservative (valine to alanine). The one mouse sequence variation found (in 3ЈUTR) was beween AA118482 (TCATAGT) and the three following sequences: our genomic clone, our 3Ј RACE product, and EST AI550109 (TCACAGT).
Reverse transcriptase-PCR (RT-PCR).
To generate cDNA template, total RNA from various cell lines or mouse Balb/C tissues was isolated using either a guanidinium isothiocyanate (Ausubel et al., 1994) or a Trizol reagent protocol (Gibco) and quantitated spectrophotometrically. A 40-L reaction consisting of 1ϫ Superscript firststrand synthesis buffer, 20 U RNasin, 0.5 mM each dNTP, 10 g RNA, 2 L (200 pmol) diluted random hexamers, and 200 U Superscript was incubated at 23°C for 10 min, at 42°C for 60 min, at 95°C for 5 min, cooled on ice, diluted to 100 L with H 2 O, and stored at Ϫ20°C. PCR was performed under reaction conditions similar to those used in the RACE experiments, except that the annealing temperature was 56°C, Taq was used instead of Pfu, and 1 L of diluted cDNA was used as template in 20-L reactions. Genomic DNA (gDNA; 100 ng) was used as a control template. The number of cycles for all PCRs shown was adjusted so product was not maximized, compared to quantities obtained with excess product as template (35 cycles for the lp A2 reactions and 23 cycles for the ␤-actin reactions). Primer combinations (sequences listed in Table 2 ), relative locations, and expected product sizes shown in Fig. 7 were: edg6Te15Ј/edg6tЈ exons 1 and 2 569 bp lpA2e2mh1/lpA2e3mh1 6 exons 2 and 3 798 bp actin-a/actin-b ␤-actin exons 630 bp
The ␤-actin primers were designed to mouse sequence corresponding to the rat sequences previously used (Raff et al., 1997) and do not amplify any product from pseudogenes in gDNA (a common problem with a large proportion of normalization studies performed). Additional primer combinations utilized to confirm and/or check expression were as follows:
edg6f/edg6e3c exons 2 and 3 517 bp edg6Te15Ј/edg6i5 exon 1 and intron 2 1252 bp spliced; 2089 bp unspliced edg6Te15Ј/edg6i4 exon 1 and intron 2 1627 bp spliced; 2464 bp unspliced 5 It is likely that there were at least double this number of clones present in the initial population. However, because adequate numbers of clones were being isolated on secondary and tertiary screens, all initial positives were not pursued to this level of purity. 6 The lpA2e2mh1 and lpA2e3mh1 primers are complementary to human sequence as well as mouse sequence. Thus these primers can be used in RT-PCR from both species. Restriction fragment length polymorphism detection and chromosomal mapping. To find restriction fragment length polymorphisms (RFLPs), primers were used to amplify products from both M. musculus (C57BL6/JEi) and M. spretus (SPRET/Ei) genomic DNA (purchased from The Jackson Laboratory). These two strains are referred to as B and S samples, respectively. We found that the primer combination edg6e/6KO2 yielded robust product from B but not S template, while edg6tЈ/6KO2 yielded robust product from S but not B template. Expected product sizes of approximately the same intensity from both species were obtained with edg6f/6mЈ, edg6a/6b, and edg6s/edg6x. By analyzing fragment sizes produced after independent digestion of these products with 4 -14 restriction enzymes, we found the following RFLPs: edg6f/6mЈ (DpnII, HinfI, NlaIII, PstI) and edg6s/edg6x (AluI, PstI, Hinf I). The HinfI RFLP in the edg6s/ edg6x PCR product was selected to screen 94 individuals from each backcross panel. PCR conditions were the same as outlined above for RACE, except the final volume was 20 L, the annealing temperature was 54°C, Taq was used instead of Pfu, and 1 L of diluted gDNA (50 ng) was used as template. Reaction products were digested by adding 10 L of a mixture consisting of 7.5 L H 2 O, 2 L of 10ϫ NEB2 (New England Biolabs restriction digest buffer 2), and 0.5 L (5 U) HinfI. Tubes were incubated at 37°C for 2 h, 6ϫ loading buffer was added, and 20 L was electrophoresed on a 1.4% agarose gel containing ethidium bromide (Ausubel et al., 1994) . The formal names of the crosses are The Jackson Laboratory interspecific backcross panels (C57BL/6J ϫ M. spretus)F 1 ϫ C57BL/6J, called Jackson BSB, and (C57BL/6JEi ϫ SPRET/Ei)F 1 ϫ SPRET/Ei, known as Jackson BSS (Rowe et al., 1994) . Raw data were submitted to The Jackson Laboratory for comparison to other markers typed to the panel. Raw data can be obtained from the Internet address http://www.jax. org/resources/documents/cmdata. Genes mapping to the same chromosomal area from other backcross screenings were determined from the Mouse Genome Database: http://www.informatics.jax.org/ menus/map_menu.shtml.
RESULTS
Determination of the Full-Length Mouse lp A2 cDNA Sequence
We designed oligonucleotides to the previously deposited human lp A2 genomic sequence (cosmid 33799, GenBank Accession No. AC002306) in regions of an exon that encoded amino acid residues conserved with other members of the lp receptor family (Fig. 1A) . PCR conditions were optimized for amplification of a single product of the correct size from mouse 129/SvJ genomic DNA. This product was confirmed to be from the lp A2 gene by subcloning and sequencing. Additional mouse- Shaded area indicates open reading frame (ORF), while the white area indicates the untranslated region (UTR). Two lines are drawn at the exon boundaries. Rodent EST clones are referred to by their GenBank accession number and the tissue from which they were isolated (in parentheses). (B) Aligned 5Ј RACE products from various tissues. With the exception of two ambiguities in the testis 2 sample and three bases at the 5Ј end, all products aligned exactly with one another and with genomic sequence (determined later). specific primers were then designed for use in both 5Ј and 3Ј RACE experiments. Because Northern blots indicated that the lp A2 transcript was most abundant in testis, kidney, and lung (J. J. A. Contos and J. Chun, unpublished observation), we used cDNA from these tissues as templates in the amplifications. Unlike the lp A1 gene, which has multiple, divergent 5Ј sequences, we found that for lp A2 , all four subcloned 5Ј RACE products from each tissue had the same sequence, although starting at slightly different points (Fig. 1B) . In 3Ј RACE experiments we obtained one product, which corresponded to three mouse expressed sequence tag (EST) clones deposited with GenBank, all from E7.5 whole embryos (Fig. 1A) . In addition to likely primer sequence at the end of one EST, there was only one other sequence variation between the cDNA and the ESTs (noted under Materials and Methods). Polyadenylation sites were identical in both the 3Ј RACE products and the one EST clone that contained a poly(A) tail (AI426967). In addition, a rat EST clone (AA894167) appeared to add a poly(A) tail at this point. The total transcript length was 2647 bp, which combined with a 250-nt poly(A) tail (Wahle, 1995) corresponds to the approximate size of the major hybridizing RNA species observed by Northern blot (J. J. A. Contos and J. Chun, unpublished observation ). An open reading frame (ORF) of 1044 bp is present in the cDNA and encodes a putative protein with 347 amino acids and 55% identity to mouse LP A1 . The AUG start codon (at nt 96) for this ORF lies within a Kozak consensus sequence (Fig. 1B) . Unlike lp A1 , there are no mRNA destabilization AUUUA consensus sequences in the lp A2 transcript.
The lp A2 Gene is Present as a Single Copy in M. musculus
To determine whether the mouse lp A2 gene was present as a single copy in the genome and whether it was divided into multiple exons (similar to the corresponding human gene), we utilized Southern blotting. M. musculus C57BL/6J ϫ Balb/C genomic DNA was digested with 16 separate restriction enzymes, electrophoresed, blotted, and probed with two regions from the mouse cDNA sequence (determined by RACE) corresponding to the separate human exons. Only a single fragment hybridized with the 5Ј probe (edg6a/6b) for each restriction digest ( Fig. 2A) . Using a 3Ј probe (edg6e3b/6mЈ), we also observed a single fragment hybridizing to gDNA digested with most of the restriction enzymes (Fig. 2B) . Of the three lanes where two fragment sizes were observed (EcoRI, BstXI, and XbaI), two (EcoRI and BstXI) could be explained by a restriction site located within the probe. The two fragments in the XbaI lane may be due to an RFLP between the C57BL/6J strain and the Balb/C strain. These results indicated that the lp A2 gene was present as a single copy in both C57BL/6J and Balb/C strains of M. musculus. In addition to determining the copy number of the gene, the sizes of the restiction fragments suggested that a small intron (Ͻ4 kb) was located between the corresponding probe fragment regions. While most of the restriction enzymes resulted in the same fragment size hybridizing with the two probes, it was different for five of them (EcoRI, PstI, SacI, BstXI, and ApaI). The ApaI difference is likely due to a restriction site located near the 3Ј end of the edg6a/6b probe. However, because none of the other four restriction sites is located in the cDNA sequence between the two probes, we concluded that there must be intervening sequence between the probe regions in the gDNA. Overall, the Southern blot results indicated that the lp A2 gene is present as a single copy in M. musculus and that multiple exons encode the transcript sequence.
The Mouse lp A2 Gene Maps to Central Chromosome 8
To map the mouse lp A2 gene, we screened for RFLPs between M. musculus C57BL/6J and M. spretus. PCR products were amplified from genomic DNA derived from each of these mouse species, digested with several restriction enzymes, and checked for RFLPs by agarose gel electrophoresis. A clear HinfI RFLP was detected in a region of intron 2 easily amplifiable with the primers edg6s/edg6x. This was used to screen two F 2 backcross panels (188 animals total) obtained from The Jackson Laboratory (Fig. 3A) . In the panels, we observed close to a 1:1 ratio for segregation of this allele, consistent with normal Mendelian principles (Figs. 3B  and 3D ). This contrasts with an RFLP from exon 4 of the lp A1 gene, where significantly different ratios and PCR product intensities were observed, due to a duplication on Chromosome 6 in M. spretus (Contos and Chun, 1998) . Based on the segregation pattern in this backcross panel, we placed the lp A2 gene at the central part of Chromosome 8 by the myosin IXb (Myo9b) and chondroitan sulfate proteoglycan 3 (Cspg3) genes (Figs. 3C and 3D ). Other backcross panel mapping studies have localized the regulator of nonsense transcripts 1 (Rent1) gene, as well as mutations for myo- dystrophy (myd) and kidney-anemia-testes (kat), very close to this locus as well (Fig. 3C) .
The Mouse and Human lp A2 Transcript Sequences Are Encoded by Three Exons
To determine the precise organization of the mouse lp A2 gene, we isolated and characterized clones from a 129/SvJ genomic DNA library. The edg6a/6b PCR was used to screen wells containing pools of 10,000 clones each. Of six initial positives, we eventually isolated three separate clones after tertiary screens. Relative locations of exons in each clone were determined with PCRs (which utilized the T7 and T3 promoter sequences flanking each end of the insert) and Southern blotting (Fig. 4A) . Together with the gDNA Southern blot data presented above and sequence data discussed below, we constructed a restriction map of ϳ25 kb of genomic sequence that included the lp A2 gene (Fig. 4A) . A 6.0-kb restriction fragment (XN5.0) that hybridized to both edg6a/6b and edg6e3b/6mЈ was subcloned into pBluescript and sequenced entirely in both directions. A more detailed restriction map of this fragment is presented in Fig. 4B , and most of its sequence is presented in Fig. 5 . By comparing the cDNA sequence to the genomic clone sequence, we determined that the mouse lp A2 gene was divided into three exons, which we termed 1 (97 bp), 2 (742 bp), and 3 (1808 bp). The intron separating exons 1 and 2 was 836 bp, while the intron separating exons 2 and 3 was 2002 bp. Intron boundaries corresponded to consensus donor and acceptor sequences (Fig. 6A ). All coding sequence was located within exons 2 and 3, which is similar to the mrec splice-variant form of the lp A1 gene (Contos and Chun, 1998) . Also as with lp A1 , the second intron separates the coding region for transmembrane domain VI and belongs to class II (i.e., inserted after the first basepair of a codon). The human lp A2 gene structure is also presented from analysis of a cosmid clone sequence that contains exons 2 and 3 (Fig. 4A) . Both the mouse and the human genes contain exactly the same   FIG. 4 . Genomic organization and restriction maps for human and mouse lp A2 genes. (A) Large-scale human and mouse genomic restriction maps. Below the genomic maps are shown the relative locations of the three mouse genomic clones isolated. In both species, the lp A2 gene is divided into three exons, shown as boxes connected by triangular lines below (which indicate splicing). Additional exons found as ESTs in the database are also shown as boxes. Lighter shaded smaller boxes indicate repetitive elements. Such additional exons and repetitive elements are not shown in the mouse map beyond the sequenced region (B). The human genomic sequence ends 500 bp upstream of exon 2; thus the placement of the human exon 1 is presumptory. (B) Higher resolution map of the sequenced mouse region. Polyadenylation sites are indicated at the end of the lp A2 gene. Several restriction enzyme sites predicted from the Southern blot to be within intron 2 are shown (EcoRI, PstI, SacI) . The 3ЈUTR contains three repetitive elements. size of exon 2 and a very similarly sized intron 2 (1973 bp in human). However, polyadenylation occurs in the human clone approximately 1 kb upstream of the analogous position in mice, which explains the shorter human transcript size observed by Northern blot . The mouse polyadenylation sequence, AUUAAA, like the AGUAAA in human, differs slightly from the stronger consensus AAUAAA (Fig. 6B) , although both have been found to be used in other genes (Birnstiel et al., 1985) . Some GU clusters are found in the appropriate location relative to the polyadenylation consensus sequence (Figs. 6B and 8C ). If these signal sequences are not utilized, transcription might proceed to produce the larger transcripts (ϳ7 kb in mouse and ϳ8 kb in human) observed in some tissues by Northern blot (in addition to the more prevalent smaller transcript).
Analysis of lp A2 Exon Splicing Patterns by RT-PCR
To determine whether the proposed splicing indicated in Fig. 4 occurs in most tissues that express the lp A2 gene, we used RT-PCR to detect spliced transcripts. Figure 7 shows that in all mouse tissues examined that splice exons 2 and 3 together, exons 1 and 2 are also spliced together. Furthermore, in this semiquantitative assay, the relative levels of each of these PCR products were similar between tissues, demonstrating that the RNA transcript consisting of spliced exons 1, 2, and 3 is the predominant form in most cell types. Together with the 5Ј RACE results, this suggests that alternate primary exons are not utilized in transcription of the mouse lp A2 gene, which contrasts with the the lp A1 gene, where multiple primary exons are found (Contos and Chun, 1998) .
There is a larger mouse transcript observed by Northern blot (of approximately 7 kb), which is most visible in the embryonic brain samples, but also detectable in other adult tissues expressing large amounts of the smaller 2.8-kb transcript (J. J. A. Contos and J. Chun, unpublished observation). To determine whether this larger transcript contains intron 2 sequence, we used primers from exon 1 and intron 2 in RT-PCRs on several of these samples. We failed to detect any product from cDNA, though these primer combinations readily amplified a larger product from gDNA (data not shown). Thus, the larger transcript size is not due to a lack of splicing exons 2 and 3.
Analysis of Human lp A2 cDNA and EST Sequences
To complete our analysis of the human lp A2 gene, we searched GenBank for all current information on human lp A2 genomic and cDNA sequences. In addition to the genomic cosmid clone from chromosome 19p12 (deposited as part of the chromosome 19 sequencing project), there were a total of 20 ESTs, as well as the cDNA sequence "Edg4" . Slightly over half (11/20) of the ESTs were from cancer cells. Alignment of all sequences demonstrated that most of the ESTs were in the 3ЈUTR, although several were found in the coding region (Fig. 8A) . One clone from embryonic brain (T02954) had a 5Ј sequence that was completely divergent from all other cDNA sequences. Aligning this sequence with the genomic clone indicated that the divergent sequence was almost exactly identical to the adjacent intron 2 sequence. This may represent reverse transcription of the hnRNA transcript before splicing. The two nearly identical prostate ESTs were best aligned by introducing a large gap approximately halfway into them, both at exactly the same point. Since these represented two separate cDNA clones from the same library (and presumably the same individual), a deletion in the tissue of origin is likely.
Smaller variations among all deposited sequences were also determined (Fig. 8B) . One notable guanine nucleotide deletion was found in the Edg4 cDNA near the end of the coding region, which was not present in an EST clone or the genomic sequence from the same area. This deletion results in a frameshift mutation and a predicted protein containing 35 extra amino acids (382 instead of 347). We confirmed that there was a G deletion in the Edg4 clone (Fig. 9C ) that was not observed in other clones (Figs. 9A and 9B) . Two other variations in the coding region were found, but one did not change the encoded amino acid, and the other was a conservative change (valine to alanine; see Materials and Methods). A total of 37 variations were observed in the 3ЈUTR. Of these, 16 were present in multiple clones, which suggests true allelic diversity rather than sequencing errors. Of the differences observed in multiple clones, nearly all (15/16) were observed in the cancerous cells, and 11 of them were observed in these cell types exclusively. Clones containing poly(A) tails were aligned, demonstrating that polyadenylation primarily occurs 15 nt downstream of the AGUAAA (9/15 clones), although it was also found 16, 17, 25, and 43 nt downstream (Figs. 6B and 8C ).
FIG. 5-Continued
DISCUSSION
The genomic characterization of the lp A2 gene reported here is necessary to understand its evolutionary origins, its relationship to other genes that have been mapped, and the relevance of sequence variations. Conserved locations of introns 1 and 2 with the lp A1 gene suggest that a common ancestral gene, distinct from the gene that gave rise to three lp B genes, duplicated and diverged into the two lp A genes. Sequence variations and frameshift mutations/deletions among multiple deposited and characterized clones indicate that previously obtained functional data need to be confirmed with unmutated clones and suggest that there may be a link between cancer and the lp A2 gene. Finally, by mapping the lp A2 gene to central mouse Chromosome 8 by several other genes and mutations, we have provided additional relevant information for understanding regulation of this genomic region and the relationship of lp A2 to previously mapped mutations.
The finding of a guanine nucleotide deletion in the ORF of the Edg4 cDNA relative to two other human clones (genomic and EST) is significant because this deletion changes the last few C-terminal amino acids and the predicted length of the translation product. We have sequenced our own human cDNA clone, which does not contain the deletion (data not shown). The mouse cDNA and genomic sequences predict a 347-amino-acid translation product, the same size as the human protein predicted from the presence of a G in the human cDNA. In addition, the sequence immediately surrounding the deleted G is identical in mouse clones and the human clones without the deletion.
Several possibilities could explain the deletion. First, it could simply have been reported due to a sequencing error. However, this possibility has been ruled out through our manual sequencing, as well as additional sequencing by the original author (Songzhu An, pers. comm. 1999) . Second, RNA editing could theoretically explain the difference, though no mechanisms have been described that insert a G into vertebrate mRNA transcripts. Third, the deletion may have arisen in that particular cDNA clone as an artifact during the cloning process. Sequencing additional lp A2 clones from the same library could eliminate this possibility. Fourth, the deleted G may represent an allelic variation in humans that is present in a proportion of the population. However, this is unlikely because the nucleotides and encoded amino acids surrounding the deletion are strictly conserved across mammals, suggesting that an essential function is imparted to the encoded protein. A final possibility is that the deletion was due to a somatic mutation in the ovary tumor cells from which the transcript was derived. This hypothesis could be confirmed by isolating and sequencing additional lp A2 clones from the same library that might also contain the deletion.
It is conceivable that the G deletion in lp A2 may have contributed to transformation of the original ovary cells that formed a tumor. First, the C-terminal regions of GPCRs contain multiple phosphorylation sites that are required for proper receptor desensitization after activation (Freedman and Lefkowitz, 1996) . Such desensitization occurs through binding of arrestin proteins to the phosphorylated receptors. Should these events be disrupted, perhaps through steric blocking of arrestin binding, signaling from activated LP A2 receptors might be extended, leading to misregulation of target effects (e.g., proliferation). Future experiments will determine whether functional differences exist between the variant protein forms, which would allow a reevaluation of the initial functional experiments resulting from expression of the Edg4 transcript in Jurkat T cells . A second line of evidence is suggestive of a role for the lp A2 gene in cancer. LPA has been shown to increase the invasiveness of tumor cells as well as activate both ovarian and breast cancer cells (Imamura et al., 1993; Xu et al., 1995; Stam et al., 1998) . In addition, high plasma LPA levels were almost invariably found in ovarian cancer patients, but not in any controls (Xu et al., 1998) . These results suggest that activation of LPA signaling pathways in ovaryderived cells can lead to cancer formation, which might occur with gain-of-function mutations.
In addition to the guanine nucleotide deletion in the coding region, other clone sequences had variations in the 3ЈUTR, especially near the poly(A) site. The large number of sequence variations in the 3ЈUTR probably reflects the fact that there were many more clones to align here. However, the fact that nearly half of the variations were found in multiple clones suggests that many of the variations represent true allelic diversity or somatic mutations, rather than cloning or sequencing errors. It has been found that 3ЈUTRs affect stability of transcripts, and when 3ЈUTRs are mutated or overexpressed, several consequences can result, including increased proliferation. For example, rearrangement in a 3ЈUTR of a cyclin G gene family member (CCND1/BCL1/PRAD1) leads to an over sixfold increase in the half-life of the transcript and is found in 10% of certain types of lymphomas and leukemias (Rimokh et al., 1994) . Furthermore, transfection of a particular 3ЈUTR can complement an immortalizationdefective mutant of SV40 T antigen in immortalization of rat embryonic fibroblasts (Powell et al., 1998) . Perhaps mutations or sequence variations in the lp A2 transcript 3ЈUTR lead to loss of normal regulation of lp A2 gene expression. Because lp A2 encodes a growth factor receptor, such misregulation of expression might affect proliferation of cells.
Sequence variations near the poly(A) site may also have a role in allowing a larger transcript form (8 kb) . Above each lane is the template cDNA used, including whole brain at various developmental stages (E, embryonic day; P, postnatal day), adult cerebellum, P7 sciatic nerve, nine additional adult organs, and five mouse cell lines. As a control, the first lane shows product from genomic DNA (gDNA) template. The ␤-actin PCR demonstrates relative levels of cDNA template used in each sample.
to be generated in humans. This larger transcript is abundant in peripheral blood leukocytes and is the predominant form in most cancerous cell lines that express the gene . One possibility for generation of the larger transcript is a lack of polyadenylation after the AGUAAA site, which would result (embryonic brain) indicate sequence that is identical to intron just 5Ј of exon 3. Each of the two clones from prostate aligns in two separate areas of the cDNA, separated by ϳ450 bp. (B) Sequence variation between all deposited ESTs, cDNAs, and the genomic clone. The last part of the coding region (with predicted amino acids indicated above) along with all the 3ЈUTR is shown. Sequences in other parts of the cDNA were identical in all clones analyzed, except T02954 (embryonic brain), which had many out-of-frame errors, likely due to seqencing errors. Where variability exists, the most common sequence is shown above and the anomalies below (in boldface type). A dash indicates a deletion. Shaded areas indicate variations present in multiple clones. The deposited Edg4 cDNA sequence (AF011466) has a G deletion in the fourth-to-last codon (boxed). (C) Polyadenylation sites in ESTs and cDNAs. All clones containing poly(A) tails are shown aligned with the genomic DNA sequence. Polyadenylation consensus sequences are shown in boldface type. Arrows above the genomic DNA sequence indicate all observed polyadenylation sites. The first site is the most common (5/11 clones), followed (in order) by more 3Ј sites. Note two additional sequence variations (past the most common poly(A) site) in the aligned clones.
in transcription proceeding further downstream. Such a longer transcript would most likely include the downstream exons (known from ESTs) found in the human genomic cosmid because the first of these begins just 5 kb downstream of the AGUAAA poly(A) signal. A contig made from the downstream ESTs has a high level of sequence similarity to Pbx genes (data not shown), which are transcription factors that cooperate with HOX and Engrailed proteins to bind DNA and activate transcription (Phelan et al., 1995; van Dijk et al., 1995; Murre, 1996, 1997) . We are currently determining the full cDNA sequence of this Pbx-like gene and the possibility that a bicistronic mRNA, including the lp A2 ORF, is transcribed. Pbx genes have been implicated in oncogenesis ever since translocation and fusion [t(1:19) (q23;p13.3)] of Pbx1 to the E2A gene were shown to precede the development of many acute lymphoblastic leukemias (Kamps et al., 1990) A similar situation may be occurring with the Pbx-like gene downstream of lp A2 , because other congenital myeloid leukemias result from t(11;19) (q23;p12-p13.1) translocations (Huret et al., 1993) , which is where the human clone containing the Pbx-like gene has been mapped. Alternatively, translocations may disrupt the lp A2 gene, which also might lead to oncogenicity.
Our finding that the lp A2 gene is present as a single copy in M. musculus indicates that this gene should be relatively straightforward to mutagenize through homologous recombination. The presence of pseudogenes or duplicated functional genes can make isolation, targeting, and specific detection by Southern blot or PCR very difficult. With respect to copy number, the lp A2 gene coding exons are similar to the analogous coding exons of lp A1 in M. musculus C57BL/6J (Contos and Chun, 1998 ), but they differ from lp A1 's exon 4 in M.
spretus, which we have shown to be duplicated on a separate chromosome.
Genes that map to the same mouse chromosomal location as lp A2 include myd, Cspg3, Rent1, and Myo9b. Homozygous myd mice have a diffuse and progressive myopathy, with focal lesions in all skeletal muscles (Lane et al., 1976) . Body and organ weights are considerably less than those of littermates, and the mean lifespan of those that survive to puberty is only 17 weeks. It has been proposed that myd is the counterpart of human mutations causing facioscapulohumeral dystrophy, which maps to distal 4q . These results, together with the expression pattern of lp A2 , indicate that lp A2 and myd are not the same gene. We found the 12-kb human Cspg3 gene, also known as Neurocan (Rauch et al., 1995) , on a separate 19p12 human cosmid (Accession No. AC002126). Thus there appears to be syntenic conservation in linkage of Cspg3 and lp A2 between human and mouse. Although it was previously proposed that Rent1 was located at 19p13.11-p13.2 (Perlick et al., 1996 ; full data not shown), we have found the human gene on two cosmid sequences from 19p12 (AC003972 and AC004517), again suggesting synteny with the mouse. Like Rent1, Myo9b was determined to be at 19p13.1 (Bahler et al., 1997) . Because this gene is not on any sequenced human genomic cosmid clone, there are no conflicting data with the 19p13.1 mapping. However, the chromosomal mapping may have had the same complications in distinguishing 19p13.1 and 19p12 as for Rent1. It is possible that all these genes are located at the border of the two cytogenetic bands. Interestingly, the myosin IXb protein contains a RhoGAP domain that suggests that it may be involved in LPA signaling pathways (Post et al., 1998) . Morphological responses to LPA- receptor stimulation rely on Rho activation (Moolenaar et al., 1997; Fukushima et al., 1998) , which in other experiments has been shown to cause phosphorylation of myosins through activation of a Rho kinase (Amano et al., 1996) . Perhaps there is a genomic regulatory link between lp A2 and this RhoGAP.
Another gene that maps fairly close to lp A2 is kat. The gross phenotype of homozygous kat mutant mice (on an RBF background), as well as homozygous kat 2J allelic mutant mice, includes polycystic kidney disease, anemia, and male sterility (Janaswami et al., 1997) . However, the homozygous kat phenotype is dependent on background strain (e.g., on a C57BL/6J background, the only gross phenotypes observed were a domed skull, dwarfing, and a mortality of ϳ50% before weaning). Interestingly, the more severe phenotypes are in organs where the lp A2 gene is most abundantly expressed. The kat gene was mapped to a small interval between the D8Mit128 and the D8Mit129 marker loci. Although we found no crossovers between lp A2 and D8Mit128 in the BSB panel, there were four crossovers with both D8Mit128 and D8Mit129 in the BSS panel. We also excluded mutations in lp A2 exons as the cause of the kat phenotype through sequencing amplified exons from both kat and RBF strains (data not shown). Thus, mutations in the lp A2 gene are likely not responsible for the kat phenotypes.
Our genomic characterization and sequence comparison results provide a large number of hypotheses that will be interesting to test in future studies. These involve the role of 3ЈUTR or coding mutations in the oncogenicity of the lp A2 gene, the possibility that mutations in lp A2 are common in certain types of cancer, and the relation of lp A2 and LPA signaling to neighboring transcription units in the genome. Furthermore, we provide the necessary information and reagents to create lp A2 targeted mutations. The genomic characterization of the lp A2 gene presented thus provides a basis for future experiments that will definitively determine the role of lp A2 in both development and disease.
